Alström syndrome: a rare genetic cardiomyopathy

Authors

  • Sheeba Thomas Department of Paediatrics, Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla, Kerala, India
  • Carol Sara Cherian Department of Paediatrics, Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla, Kerala, India
  • Jacob Abraham Department of Paediatrics, Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla, Kerala, India
  • Jewel Maria George Department of Paediatrics, Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla, Kerala, India

DOI:

https://doi.org/10.18203/2349-3291.ijcp20252972

Keywords:

Alström syndrome, Dilated cardiomyopathy, Pediatric cardiomyopathy

Abstract

With an incidence estimated at less than 1 100 000, Alstrom syndrome (AS) was first reported in 1959. AS is an autosomal recessive multi organ disorder, characterized by childhood obesity, adult short stature with initial accelerated childhood linear growth, progressive cone-rod dystrophy leading to blindness, and sensorineural hearing loss. Acanthosis nigricans, hyperinsulinemia, hypertriglyceridemia, hypothyroidism, infertility (hypergonadotrophic hypogonadism), and early-onset diabetes mellitus are the endocrinology consequences. In children dilated cardiomyopathy is the main cause of mortality, in older affected patients, renal failure is the main cause of death. We report a rare case of a 04-month-old girl with dilated cardiomyopathy, Global developmental delay, congenital nystagmus caused by ALMS1 mutation. This study demonstrates that genetic testing for cardiomyopathy without an obvious acquired cause help in determining the underlying cause, managing the condition appropriately, diagnosing syndromic forms early, and keeping an eye on and initiating pre-symptomatic treatment for related extracardiac complications.

Metrics

Metrics Loading ...

References

Hearn T, Renforth GL, Spalluto C, Hanley NA, Piper K, Brickwood S, et al. Mutation of ALMS1, a large gene with a tandem repeat encoding 47 amino acids, causes Alstrom syndrome. Nature Genet. 2002;31(1):79-83. DOI: https://doi.org/10.1038/ng874

Collin GB, Marshall JD, Ikeda A, So WV, Russell-Eggitt I, Maffei P, et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nature Genet. 2002;31(1):74-78. DOI: https://doi.org/10.1038/ng867

Hearn T, Spalluto C, Phillips VJ, Renforth GL, Copin N, Hanley NA, et al. Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes. 2005;54(5):1581-7. DOI: https://doi.org/10.2337/diabetes.54.5.1581

Li G, Vega R, Nelms K, Gekakis N, Goodnow C, McNamara P, et al. A role for Alstrom syndrome protein, alms1, in kidney ciliogenesis and cellular quiescence. PLoS Genet. 2007;3(1):e8. DOI: https://doi.org/10.1371/journal.pgen.0030008

Marshall JD, Bronson RT, Collin GB, Nordstrom AD, Maffei P, Paisey RB, et al. New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch Internal med. 2005;165(6):675-83. DOI: https://doi.org/10.1001/archinte.165.6.675

Satman I, Yilmaz MT, Gursoy N, Karsidag K, Dinccag N, Ovali T, et al. Evaluation of insulin resistant diabetes mellitus in Alstrom syndrome: a longterm prospective follow-up of three siblings. Diab Res Clin Pract. 2002;56(3):189-96. DOI: https://doi.org/10.1016/S0168-8227(02)00004-9

Downloads

Published

2025-09-23

How to Cite

Thomas, S., Cherian, C. S., Abraham, J., & George, J. M. (2025). Alström syndrome: a rare genetic cardiomyopathy. International Journal of Contemporary Pediatrics, 12(10), 1714–1717. https://doi.org/10.18203/2349-3291.ijcp20252972

Issue

Section

Case Reports